Back to Journals » OncoTargets and Therapy » Volume 13

RETRACTED ARTICLE: MiR-181c-5p Mitigates Tumorigenesis in Cervical Squamous Cell Carcinoma via Targeting Glycogen Synthase Kinase 3β Interaction Protein (GSKIP)

Authors Li N, Cheng C, Wang T

Received 8 January 2020

Accepted for publication 6 May 2020

Published 21 May 2020 Volume 2020:13 Pages 4495—4505

DOI https://doi.org/10.2147/OTT.S245254

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Leo Jen-Liang Su



This paper has been retracted.

Li N, Cheng C, Wang T. Onco Targets Ther. 2020;13:4495–4505.

We, the Editor and Publisher of the journal OncoTargets and Therapy have retracted the published article.

Following publication of the article, concerns were raised about the duplication of images from Figures 4 and 6 with images from unrelated articles. Specifically,

  • Images for Figure 4B have been duplicated with images for Figure 3F from Zhang J, He H, Wang K, et al. miR-326 inhibits the cell proliferation and cancer stem cell-like property of cervical cancer in vitro and oncogenesis in vivo via targeting TCF4. Ann Transl Med. 2020;8(24):1638. https://doi.org/10.21037/atm-20-6830 and Figure 3D from Wu J, Zhang C, Chen L. MiR-511 Mimic Transfection Inhibits the Proliferation, Invasion of Osteosarcoma Cells and Reduces Metastatic Osteosarcoma Tumor Burden in Nude Mice via Targeting MAPK1. Cancer Biomark. 2019:26(3):343–351.
  • The images for Figure 6A have been duplicated with images for Figure 1B from Bai J, Jiao WY. Down-Regulation of ZEB1 by miR-199a-3p Overexpression Restrains Tumor Stem-Like Properties and Mitochondrial Function of Non-Small Cell Lung Cancer. Onco Targets Ther. 2020;13:4607-4616. https://doi.org/10.2147/OTT.S244525.
  • Images for Figure 6D have been duplicated with images for Figure 4C from Shi S, Hu X, Xu J, Liu H, Zou L. Retracted Article: MiR-320d suppresses the progression of breast cancer via lncRNA HNF1A-AS1 regulation and SOX4 inhibition. RSC Adv. 2018;8:19196-19207; Figure 5B from Lei K, Ma B, Shi P, et al. Icariin Mitigates the Growth and Invasion Ability of Human Oral Squamous Cell Carcinoma via Inhibiting Toll-Like Receptor 4 and Phosphorylation of NF-κB P65. Onco Targets Ther. 2020;13:299-307. https://doi.org/10.2147/OTT.S214514 and Figure 6C from Jiang Z, Mao Z. Retracted Article: Astragaloside IV (AS-IV) alleviates the malignant biological behavior of hepatocellular carcinoma via Wnt/β-catenin signaling pathway. RSC Adv. 2019;9: 35473-35482.

The corresponding author did not respond to our queries and was unable to provide a satisfactory explanation for how the images came to be duplicated or provide satisfactory original data for the study. As verifying the validity of published work is core to the integrity of the scholarly record, the Publisher and Editor requested to retract the article and the corresponding author was notified of this decision.

We have been informed in our decision-making by our editorial policies and COPE guidelines.

The retracted article will remain online to maintain

Creative Commons License © 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.